Omega 3 fatty acid treatment in autism

Gal Meiri; Yoav Bichovsky; R. H. Belmaker

doi:10.1089/cap.2008.0123

Omega 3 fatty acid treatment in autism

Gal Meiri, Yoav Bichovsky, R. H. Belmaker

Research output: Contribution to journal › Article › peer-review

55 Scopus citations

Abstract

Objective: The purpose of this study was to determine the efficacy and safety of omega-3 fatty acids for children with autistic spectrum disorder (ASD). Methods: This was an open-label pilot study. Ten children aged 4-7 years old with ASD according to the Diagnostic and Statistical Manual of Mental Disorders, 4^th edition (DSM-IV), were given 1 gram daily of omega-3 fatty acids for 12 weeks. The main outcome measure used was the Autism Treatment Evaluation Checklist (ATEC). These data were collected between July, 2006, and June, 2007. Results: Of the 9 subjects who completed the study, 8 showed improvement of about 33% on the Autism Treatment Evaluation Checklist (ATEC). None worsened and no side effects were reported. Conclusions: Omega-3 fatty acids appear to be safe and might be helpful for children suffering from ASD. Further study is needed with a larger number of children in a double-blind design and with various doses of omega-3 fatty acids.

Original language	English
Pages (from-to)	449-451
Number of pages	3
Journal	Journal of Child and Adolescent Psychopharmacology
Volume	19
Issue number	4
DOIs	https://doi.org/10.1089/cap.2008.0123
State	Published - 1 Aug 2009

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Psychiatry and Mental health
Pharmacology (medical)

Access to Document

10.1089/cap.2008.0123

Cite this

@article{fff784b7e8b64e40bbeb4b6b95132fdb,

title = "Omega 3 fatty acid treatment in autism",

abstract = "Objective: The purpose of this study was to determine the efficacy and safety of omega-3 fatty acids for children with autistic spectrum disorder (ASD). Methods: This was an open-label pilot study. Ten children aged 4-7 years old with ASD according to the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV), were given 1 gram daily of omega-3 fatty acids for 12 weeks. The main outcome measure used was the Autism Treatment Evaluation Checklist (ATEC). These data were collected between July, 2006, and June, 2007. Results: Of the 9 subjects who completed the study, 8 showed improvement of about 33% on the Autism Treatment Evaluation Checklist (ATEC). None worsened and no side effects were reported. Conclusions: Omega-3 fatty acids appear to be safe and might be helpful for children suffering from ASD. Further study is needed with a larger number of children in a double-blind design and with various doses of omega-3 fatty acids.",

author = "Gal Meiri and Yoav Bichovsky and Belmaker, {R. H.}",

year = "2009",

month = aug,

day = "1",

doi = "10.1089/cap.2008.0123",

language = "English",

volume = "19",

pages = "449--451",

journal = "Journal of Child and Adolescent Psychopharmacology",

issn = "1044-5463",

publisher = "Mary Ann Liebert Inc.",

number = "4",

}

TY - JOUR

T1 - Omega 3 fatty acid treatment in autism

AU - Meiri, Gal

AU - Bichovsky, Yoav

AU - Belmaker, R. H.

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Objective: The purpose of this study was to determine the efficacy and safety of omega-3 fatty acids for children with autistic spectrum disorder (ASD). Methods: This was an open-label pilot study. Ten children aged 4-7 years old with ASD according to the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV), were given 1 gram daily of omega-3 fatty acids for 12 weeks. The main outcome measure used was the Autism Treatment Evaluation Checklist (ATEC). These data were collected between July, 2006, and June, 2007. Results: Of the 9 subjects who completed the study, 8 showed improvement of about 33% on the Autism Treatment Evaluation Checklist (ATEC). None worsened and no side effects were reported. Conclusions: Omega-3 fatty acids appear to be safe and might be helpful for children suffering from ASD. Further study is needed with a larger number of children in a double-blind design and with various doses of omega-3 fatty acids.

AB - Objective: The purpose of this study was to determine the efficacy and safety of omega-3 fatty acids for children with autistic spectrum disorder (ASD). Methods: This was an open-label pilot study. Ten children aged 4-7 years old with ASD according to the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV), were given 1 gram daily of omega-3 fatty acids for 12 weeks. The main outcome measure used was the Autism Treatment Evaluation Checklist (ATEC). These data were collected between July, 2006, and June, 2007. Results: Of the 9 subjects who completed the study, 8 showed improvement of about 33% on the Autism Treatment Evaluation Checklist (ATEC). None worsened and no side effects were reported. Conclusions: Omega-3 fatty acids appear to be safe and might be helpful for children suffering from ASD. Further study is needed with a larger number of children in a double-blind design and with various doses of omega-3 fatty acids.

UR - http://www.scopus.com/inward/record.url?scp=69549133857&partnerID=8YFLogxK

U2 - 10.1089/cap.2008.0123

DO - 10.1089/cap.2008.0123

M3 - Article

C2 - 19702497

AN - SCOPUS:69549133857

SN - 1044-5463

VL - 19

SP - 449

EP - 451

JO - Journal of Child and Adolescent Psychopharmacology

JF - Journal of Child and Adolescent Psychopharmacology

IS - 4

ER -

Omega 3 fatty acid treatment in autism

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this